Molecular determinants of metastatic transformation.
In recent years, experimental systems have developed to analyze genetic and epigenetic regulation of the metastatic phenotype. Numerous studies have uncovered a potent role for transforming oncogenes in metastatic conversion. In addition, it has been shown that oncoprotein products operate in a dose-dependent fashion. The continued expression of oncoproteins is required to induce and regulate metastatic dissemination of tumor cells and, consequently, many of the signal transduction pathways that are controlled by the oncogene products can regulate metastasis. Exogenous growth factors that act through these same pathways also alter metastatic potential. Some primary and immortalized cells can be transformed by oncogenes but remain completely benign and nonmetastatic. Malignant transformation can be achieved in these cells through the cooperative interaction of specific oncogenes or loss of active suppression regulated by recessive genetic determinants. Therefore, it is likely that tumor cells acquire the metastatic phenotype through the cooperative interaction of dominant and recessive genetic alterations. This model is consistent with the correlative data accumulating in studies of human tumor specimens where more malignant carcinomas often contain both activating mutations in oncogenes and either inactivating mutations or loss of tumor-suppressor genes.
Egan
S E
SE
Manitoba Institute of Cell Biology, University of Manitoba, Winnipeg, Canada.
Wright
J A
JA
Greenberg
A H
AH
D016475:3T3 Cells; D000818:Animals; D002471:Cell Transformation, Neoplastic / Q000235:genetics / Q000473:pathology; D004843:Epistasis, Genetic; D005784:Gene Amplification; D015972:Gene Expression Regulation, Neoplastic; D005799:Genes, Dominant; D005808:Genes, Recessive; D016147:Genes, Tumor Suppressor; D011905:Genes, ras; D006133:Growth Substances / Q000235:genetics / Q000502:physiology; D051379:Mice; D008819:Mice, Nude; D009362:Neoplasm Metastasis / Q000235:genetics*; D009363:Neoplasm Proteins / Q000235:genetics / Q000502:physiology; D009369:Neoplasms / Q000235:genetics / Q000473:pathology; D009374:Neoplasms, Experimental / Q000235:genetics; D009857:Oncogenes; D010641:Phenotype; D011505:Protein-Tyrosine Kinases / Q000235:genetics / Q000502:physiology; D015398:Signal Transduction
D006133:Growth Substances; D009363:Neoplasm Proteins; D011505:Protein-Tyrosine Kinases